Centrum Doskonałości w dziedzinie Medycyny Molekularnej
   
       
     
Lecture by dr. Ryszard Szydło
   
     

Lodz, Rectorate of Medical University (Main Hall),
November 19th (Friday)
,
13:00

Programme:
APPROPRIATE AND INAPPROPRIATE ANALYSES
OF DATA FROM MEDICAL RESEARCH

Rectorate of Medical University of Lodz
4 Kosciuszki Ave.
90-419 Lodz


Ryszard Szydło, PhD (Biology), MSc (Medical Statistics)

Since 1989 has worked in the Department of Haematology at the Hammersmith Hospital , London - first under Prof. John Goldman (world expert on CML) and now under Prof. Jane Apperley (current president of the EBMT).  Collaborates with clinicians and scientists in the department, and with colleagues nationally and internationally working on the biology and treatment of haematologic disorders. Core research interests include stem cell transplantation for chronic myeloid leukaemia, the use of donor lymphocyte infusions for the treatment of disease relapse, the monitoring of minimal residual disease by PCR, bone marker studies in multiple myeloma, and methodological studies for the analysis of survival data. Invited speaker to national and international conferences, and author and co-author of nearly 80 publications (with the majority in Blood, the British Journal of Haematology and Bone Marrow Transplantation). Selected recent publications include: 1) E Terpos , RM Szydlo et al "Soluble receptor activator of nuclear factor kB ligand >(RANKL)/osteoprotegerin (OPG) ratio predicts survival in multiple myeloma. Proposal for a novel prognostic index", Blood , 2003 Aug 1,102(3): 1064 -1069; 2)D Marin, S Marktel , RM Szydlo, et al "Survival of patients with chronic-phase chronic myeloid leukaemia on imatinib after failure of interferon alfa", Lancet , 2003 Aug 23, 362 (9384):617-9; 3)RM Szydlo. "Statistical Evaluation of HSCT Data" in Haemopoietic Stem Cell Transplantaion, The ESH/EBMT, 2004 Revised Edition, (eds: Apperley, Careras, Gluckman, Gratwohl, Masszi), May, 2004; 4)T Vulliamy, A Marrone, RM Szydlo, A Walne, P Mason and I Dokal. "Disease anticipation is associated with progressive telomere shortening in families with mutations in the RNA component of telomerase", Nature Genetics , 2004 May; 36 (5): 447-9.